Skip to main content

Table 4 Fibrosis stage before and 72 weeks after SMV/SOF therapy in SVR patients

From: NS34A resistance-associated substitutions in chronic hepatitis C in Upper Egypt and regression of liver fibrosis after direct-acting antiviral therapy

Liver fibrosis stage Before treatment (baseline) 72 weeks after treatment P value
F0 10 (17.5%) 20 (35%) 0.001*
F1 4 (7%) 13 (22.9%) 0.001*
F2 17 (29.8%) 7 (12.3%) 0.001*
F3 10 (17.5%) 2 (3.5%) 0.001*
F4 16 (28.2%) 15 (26.3%) ns
  1. Total cases = 57
  2. *Statistically significant